Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care... Show more
Ventas, Inc. stands as a premier S&P 500 healthcare REIT, with a diversified portfolio emphasizing senior housing, outpatient medical facilities, and life sciences properties. Approximately 60% of its assets are in SHOP, where Ventas leverages proprietary analytics and operational expertise to partner with top-tier operators. This positioning capitalizes on the secular growth in healthcare real estate, driven by an expanding elderly population requiring assisted living and memory care.
Competitively, Ventas holds a leading market share alongside peers like Welltower, benefiting from investment-grade credit ratings that enable cost-effective capital access. Recent portfolio optimization, including lease extensions and targeted acquisitions, enhances occupancy and revenue quality. Medium-term, the company's expansion into high-growth outpatient and research segments mitigates risks from senior housing cyclicality, while global diversification adds resilience.
The Q1 2026 earnings release on April 27, followed by a conference call on April 28, represents a pivotal near-term event. Analysts anticipate robust revenue of around $1.58 billion and EPS of $0.91, with focus on SHOP same-facility NOI trends and investment updates. Strong results could prompt upward revisions to full-year guidance, bolstering sentiment.
Ongoing senior housing deals, with a $2.5 billion target for 2026, offer deployment catalysts, as does potential dividend growth following recent hikes. Analyst activity remains active, with recent "Buy" reiterations from firms like Goldman Sachs at $94 targets, reflecting optimism on occupancy recovery. Consensus trends show stable "Buy" profiles, with price targets clustered around $90-$93 and minimal downgrades.
The healthcare REIT sector benefits from irreversible demographic shifts, with U.S. seniors projected to grow significantly, fueling demand for senior housing amid labor shortages in home care. Ventas' SHOP occupancy gains underscore this tailwind, though elevated labor and supply costs pressure margins.
Interest rates are a key sensitivity: as a debt-financed REIT, Ventas faces higher borrowing costs in rising-rate environments, impacting FFO (Funds From Operations). Prospective Fed easing could compress cap rates, supporting acquisitions and valuations. Broader inflation moderates expense growth, while regulatory support for healthcare spending aids outpatient demand. Geopolitical stability influences commodity inputs, but Ventas' focus on essential services provides defensive qualities.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying potential bullish, bearish, or sideways movements for stocks, ETFs, and other assets over the next week or month. By analyzing vast datasets, it spots emerging trends, evaluates breakout or reversal opportunities, and provides predictions across thousands of tradable instruments. Features include searchable categories by timeframe, historical performance context, and customizable alerts for timely insights. Ideal for forward-looking market strategies, it empowers users to navigate volatility with data-driven confidence—explore it today for enhanced decision-making.
Ventas' 2026 guidance, issued alongside Q4 2025 results, projects substantial SHOP NOI growth and benefits from $2+ billion in accretive senior housing investments. Dividend increases signal confidence in cash flow sustainability. Long-term drivers include demographic expansion, with baby boomers driving senior living needs, alongside portfolio shifts toward higher-margin outpatient and life sciences assets.
Cost discipline and technology adoption, such as AI-driven property management, support margin durability. Competitive threats from new entrants are tempered by Ventas' scale, while regulatory tailwinds in healthcare funding persist. Consensus analyst expectations embed EPS growth of ~48% in 2026, aligning with structural positioning. Capital allocation priorities—balancing investments, debt reduction, and returns—will shape trajectory amid evolving rates.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a real estate investment trust
Industry PublishingBooksMagazines
A.I.dvisor indicates that over the last year, VTR has been closely correlated with WELL. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTR jumps, then WELL could also see price increases.
| Ticker / NAME | Correlation To VTR | 1D Price Change % |
|---|---|---|
| VTR | 100% | +3.20% |
| VTR (2 stocks) | 88% Closely correlated | +2.88% |
| Publishing: Books/Magazines (20 stocks) | 75% Closely correlated | +0.96% |
| Consumer Services (227 stocks) | 8% Poorly correlated | +0.33% |
VTR saw its Momentum Indicator move above the 0 level on June 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for VTR just turned positive on June 12, 2026. Looking at past instances where VTR's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
VTR moved above its 50-day moving average on June 23, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VTR crossed bullishly above the 50-day moving average on June 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTR advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
VTR broke above its upper Bollinger Band on July 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VTR entered a downward trend on June 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. VTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.308) is normal, around the industry mean (2.746). VTR's P/E Ratio (162.364) is considerably higher than the industry average of (59.402). VTR's Projected Growth (PEG Ratio) (1.717) is slightly lower than the industry average of (3.232). VTR has a moderately low Dividend Yield (0.022) as compared to the industry average of (0.059). P/S Ratio (6.883) is also within normal values, averaging (6.332).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.